Citrucel Tablet
NDC Package 0135-0199-08
Package Information
Citrucel (methylcellulose) tablets is a medication used to treat constipation. This formulation utilizes a tablet delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0135-0199 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 198750 - methylcellulose 500 MG Oral Tablet
- RxCUI: 352178 - Citrucel 500 MG Oral Tablet
- RxCUI: 352178 - methylcellulose 500 MG Oral Tablet [Citrucel]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0135 - Haleon Us Holdings Llc
- 0135-0199 - Citrucel
- 0135-0199-08 - 50 POUCH in 1 CARTON / 2 TABLET in 1 POUCH (0135-0199-06)
- 0135-0199 - Citrucel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0135-0199). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0135-0199-08 identifies a specific commercial package of 50 pouch in 1 carton / 2 tablet in 1 pouch (0135-0199-06) of Citrucel, a human over the counter drug labeled by Haleon Us Holdings Llc. This tablet is formulated for oral use and contains methylcellulose (4000 mpa.s) as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on February 01, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat constipation. It increases the bulk in your stool, an effect that helps to cause movement of the intestines. It also works by increasing the amount of water in the stool, making the stool softer and easier to pass. Psyllium, one type of bulk-forming laxative, has also been used along with a proper diet to treat high cholesterol.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00135019908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.